Free Trial

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Sivik Global Healthcare LLC

Surgery Partners logo with Medical background

Sivik Global Healthcare LLC lessened its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 37.5% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 125,000 shares of the company's stock after selling 75,000 shares during the quarter. Surgery Partners accounts for about 1.6% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 27th largest holding. Sivik Global Healthcare LLC owned approximately 0.10% of Surgery Partners worth $2,969,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Empowered Funds LLC acquired a new stake in Surgery Partners in the fourth quarter valued at approximately $245,000. Rhumbline Advisers grew its position in Surgery Partners by 1.3% in the fourth quarter. Rhumbline Advisers now owns 121,852 shares of the company's stock valued at $2,580,000 after acquiring an additional 1,588 shares in the last quarter. Principal Financial Group Inc. grew its position in Surgery Partners by 8.8% in the fourth quarter. Principal Financial Group Inc. now owns 49,549 shares of the company's stock valued at $1,049,000 after acquiring an additional 3,997 shares in the last quarter. Sanctuary Advisors LLC grew its position in Surgery Partners by 27.5% in the fourth quarter. Sanctuary Advisors LLC now owns 24,778 shares of the company's stock valued at $525,000 after acquiring an additional 5,351 shares in the last quarter. Finally, Alberta Investment Management Corp grew its position in Surgery Partners by 128.9% in the fourth quarter. Alberta Investment Management Corp now owns 67,180 shares of the company's stock valued at $1,422,000 after acquiring an additional 37,827 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on SGRY shares. Barclays lowered their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 27th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. Macquarie lowered their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research report on Tuesday, March 11th. Finally, Benchmark reiterated a "buy" rating and set a $35.00 target price on shares of Surgery Partners in a research note on Monday, April 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $33.56.

Check Out Our Latest Report on SGRY

Surgery Partners Stock Performance

Surgery Partners stock opened at $19.30 on Friday. The stock has a 50 day moving average of $22.36 and a 200-day moving average of $22.66. Surgery Partners, Inc. has a 52 week low of $18.87 and a 52 week high of $33.97. The stock has a market cap of $2.47 billion, a P/E ratio of -12.61 and a beta of 1.93. The company has a current ratio of 1.89, a quick ratio of 1.73 and a debt-to-equity ratio of 1.09.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. The firm had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. During the same quarter last year, the business earned $0.10 earnings per share. The business's revenue for the quarter was up 8.2% compared to the same quarter last year. On average, analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Read More

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Surgery Partners Right Now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines